NYSE:BIO - Bio-Rad Laboratories, Inc.
$334.16
 $-0.33
-0.10%
4:00PM EDT
2019-09-16
Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated on March 10, 1975, is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. The Company manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company's Life Science segment develops, manufactures, sells and services reagents, apparatus and instruments used for biological research. The Company's Clinical Diagnostics segment develops, manufactures, sells and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. As of December 31, 2016, Bio-Rad sold more than 8,000 products and services to a client base, including scientific research, healthcare, education and government customers around the world.Life ScienceThe Company's Life Science segment markets and develops, manufactures and markets a range of over 5,000 reagents, apparatus and laboratory instruments that serve a global customer base. Read more at  reuters.com
sector:  health care
industry:  biotechnology laboratory analytical instruments
the data below are updated and published after 9pm EDT each trading day
  BIO     avg for
industry  
  avg for
sector  
42 stocks weight:  1. 01 K 0. 00   0. 00  
42 stocks rank:  17. 00   99. 92   1. 30 K
# analyst opinions:  2. 00   10. 11   12. 97  
mean recommendation:  1. 50   1. 97   2. 07  

quick ratio:  3. 05   2. 31   1. 92  
current ratio:  4. 68   3. 22   2. 45  

target price low:  380. 00   141. 89   109. 66  
target price avg:  390. 00   150. 28   131. 81  
target price high:  400. 00   160. 58   149. 31  
1-yr high:  344. 20   140. 15   134. 46  
last close:  334. 15   132. 23   117. 08  
50-day avg:  324. 42   127. 35   117. 12  
200-day avg:  291. 33   119. 58   113. 76  
1-yr low:  220. 10   93. 42   93. 76  
volume:  314. 55 K 1. 73 M 3. 04 M
50-day avg volume:  177. 90 K 1. 64 M 4. 09 M
200-day avg volume:  207. 69 K 1. 53 M 4. 63 M

1-day return:  -0. 28 % 0. 30 % 0. 18 %
this week return:  -0. 10 % 2. 30 % 0. 77 %
12-wk return:  6. 90 % 5. 50 % 2. 99 %
52-wk return:  13. 49 % 7. 32 % 4. 64 %

enterprise value (EV):  9. 65 B 15. 86 B 112. 94 B
market cap:  9. 98 B 41. 11 B 4. 95 T
EBITDA:  351. 73 M 837. 68 M 7. 74 B
enterprise multiple (EV/EBITDA):  27. 43   19. 60   10. 42  
enterprise/revenue (EV/R):  4. 22   7. 74   22. 18  
total revenue:  2. 29 B 3. 76 B 31. 64 B
total debt:  661. 07 M 1. 28 B 16. 97 B
debt/equity:  12. 05   46. 99   141. 17  
net income (common):  904. 80 M 857. 90 M 3. 90 B

shares outstanding:  24. 70 M 207. 52 M 1. 27 B
shares:  21. 28 M 196. 84 M 1. 22 B
shares short:  552. 77 K 3. 98 M 13. 52 M
shares short prior month:  409. 76 K 3. 10 M 12. 50 M
short ratio:  2. 59   4. 04   3. 68  
short % of float:  2. 57 % 3. 32 % 2. 78 %
total cash/share:  32. 95   11. 72   8. 82  
total cash:  981. 86 M 1. 29 B 5. 99 B
free cash flow:  230. 62 M 448. 42 M 4. 78 B
operating cash flow:  365. 63 M 728. 70 M 5. 77 B

book value:  184. 12   55. 01   26. 68  
price/book:  1. 81   5. 45   6. 12  
gross profits:  1. 23 B 1. 97 B 35. 94 B
operating margins:  9. 45 % -17. 11 % -202. 61 %
EBITDA margins:  15. 37 % 20. 30 % 24. 32 %
profit margins:  39. 53 % 23. 14 % 14. 56 %
gross margins:  54. 35 % 53. 24 % 58. 52 %

1-yr max volatility:  17. 14 % --- ---
1-yr mean volatility:  1. 31 % 1. 10 % 0. 86 %

1-yr EPS:  29. 97   9. 44   4. 02  
forward EPS:  8. 75   4. 35   6. 65  
P/E:  11. 15   20. 81   23. 91  
forward P/E:  38. 23   25. 21   12. 40  
PE/G:  0. 37   -35. 39   -1. 71  
growth:  30. 40 % 9. 40 % 102. 21 %
earnings high:  1. 45   0. 92   1. 61  
earnings avg:  1. 40   0. 89   1. 50  
earnings low:  1. 36   0. 86   1. 39  
revenue high:  568. 67 M 979. 89 M 8. 82 B
revenue avg:  565. 03 M 970. 48 M 8. 66 B
revenue low:  561. 40 M 960. 73 M 8. 48 B
earnings growth:  123. 90 % 22. 94 % 138. 30 %
1-qtr earnings growth:  123. 40 % 22. 39 % 256. 65 %
return on assets:  1. 93 % 5. 37 % 5. 55 %
return on equity:  17. 87 % 17. 34 % 20. 45 %
revenue growth:  -0. 60 % 5. 03 % 39. 99 %
revenue/share:  76. 70   30. 06   52. 14  

beta (1yr vs S&P500):  1. 05   1. 12   0. 87  
sharpe (1yr):  0. 40   0. 61   0. 48  

held % insiders:  14. 62 % 10. 55 % 3. 59 %
held % institutions:  78. 00 % 81. 54 % 67. 25 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-09-16 : BIO
.    121.027 =         121.027 :: --> INITIAL WEIGHT <--
.                               --> FUNDAMENTALS <--
.    x 2.162 =         261.666 :: P/E factor
.    x 1.285 =         336.248 :: PE/G factor
.    x 1.706 =         573.528 :: beta factor
.    x 0.916 =         525.234 :: sharpe factor
.     x 1.66 =         871.637 :: current ratio factor
.    x 0.928 =         808.875 :: quick ratio factor
.    x 1.224 =         989.727 :: short ratio factor
.    x 1.012 =        1001.465 :: return on assets factor
.    x 1.198 =        1199.643 :: return on equity factor
.    x 1.676 =        2010.034 :: earnings growth factor
.    x 1.622 =        3260.436 :: EV/R factor
.    x 1.009 =        3289.889 :: price-to-book factor
.    x 0.866 =        2850.393 :: enterprise-to-EBITDA factor
.    x 0.965 =        2750.855 :: enterprise-multiple vs industry factor
.    x 2.221 =        6109.182 :: debt-to-revenue factor
.    x 1.973 =        12051.36 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.863 =       34508.461 :: sector+industry 1-year gains factor
.    x 1.009 =       34817.713 :: industry 12-weeks return factor
.    x 1.315 =       45792.995 :: industry 2-weeks return factor
.    x 1.081 =        49502.54 :: company one-year gains+dividend factor
.    x 5.213 =      258057.496 :: company 13 weeks' performance factor
.    x 1.271 =       327937.41 :: 5-day avg > 200-day avg
.    x 1.082 =      354941.091 :: 5-day avg > 50-day avg
.    x 1.114 =      395249.551 :: 50-day avg > 200-day avg
.    x 4.121 =     1628827.432 :: overall "drift" factor
.    x 0.943 =     1536781.923 :: largest single-day price delta factor
.    x 0.998 =     1533957.862 :: volatility factor
.    x 0.998 =     1530515.758 :: 42-day volatility factor
.   x 13.008 =    19909307.869 :: notable returns (10) + performance factor
.    x 4.506 =    89717861.218 :: industry vs s&p500 factor
.    x 2.211 =   198340294.618 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.676 =   332428756.977 :: forward EPS factor
.    x 1.577 =   524140684.466 :: forward P/E factor
.    x 1.209 =   633786164.827 :: industry recommendation factor
.     x 2.42 =  1533611835.113 :: company recommendation factor
.    x 1.212 =  1858603112.339 :: factor historical industry gain for week 37
.     x 1.46 =  2712801158.473 :: target low factor
.    x 1.136 =   3082491039.56 :: target mean factor
.    x 1.019 =  3139963298.868 :: target high factor
.   x 10.788 = 33875122992.265 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         429.013 :: reduced for readability
.  + 577.478 =        1006.491 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                   1006.491 :: FINAL WEIGHT for NYSE:BIO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org